Table 1.
Temporal Trends in Pulmonary Nodule Detection Rates (%) Across Distinct Clinical Populations and Gender Subgroups.
Fig 1.
Trends in Pulmonary Nodule Detection Rates in (A) Outpatients and (B) Health Examination Populations.
Table 2.
Temporal Trends in Pulmonary Nodule Detection Rates (%) Across Distinct Clinical Populations and Gender Subgroups after Adjusting for AI-related effects.
Fig 2.
Trends in pulmonary nodule detection rates among (A) pre-2019 AI-implemented hospitals (outpatients), (B) Pre-2019 AI-implemented hospitals (health examinations), (C) post-Dec.
2023 AI-implemented hospitals (outpatients), (D) post-Dec. 2023 AI-implemented hospitals (health examinations), (E) pre-Dec. 2020 AI-implemented hospitals (outpatients), and (F) pre-Dec. 2020 AI-implemented hospitals (health examinations).
Table 3.
Temporal Trends in Pulmonary Nodule Detection Rates (%) Across Hospital Tier and Specialty Subgroups.
Fig 3.
Comparative trends in pulmonary nodule and lung tumor detection rates across (A) pre-2019 AI-implemented hospitals (outpatients), (B) pre-2019 AI-implemented hospitals (health examinations), (C) post-Dec.
2023 AI-implemented hospitals (outpatients), (D) post-Dec. 2023 AI-implemented hospitals (health examinations), (E) pre-Dec. 2020 AI-implemented hospitals (outpatients), and (F) pre-Dec. 2020 AI-implemented hospitals (health examinations).
Fig 4.
Comparative trends in pulmonary nodule and lung cancer detection rates across (A) pre-2019 AI-implemented hospitals (outpatients), (B) pre-2019 AI-implemented hospitals (health examinations), (C) post-Dec.
2023 AI-implemented hospitals (outpatients), (D) post-Dec. 2023 AI-implemented hospitals (health examinations), (E) pre-Dec. 2020 AI-implemented hospitals (outpatients), and (F) pre-Dec. 2020 AI-implemented hospitals (health examinations).